Table 4 BCRF-survival in subgroups of patients according to pre- and postoperative ADT receivers and non-receivers and their postoperative ADT-response
| Without ADT after surgery | With ADT after surgery | |
|---|---|---|---|
Patients without preoperative ADT, n = 9 (20 %) | Total without / with ADT | 3 (33.3 %) | 6 (66.7 %) |
Of the above: BCRF-survival after salvage ePLND, n (%) | 2 of 3 (66.7 %) | 5 of 6 (83.3 %) | |
Duration of BCRF-survival after salvage ePLND (months): 1. mean duration ± SD | 18 ± 3 | 33.4 ± 15.8 | |
2. median duration | 18 | 36 | |
3. min-max duration | 15–21 | 6–53 | |
Patients with preoperative ADT n = 36 (80 %) | Total without / with ADT | 2 (5.6 %) | 34 (94.4 %) |
Of the above: BCRF-survival after salvage ePLND, n (%) | 2 of 2 (100 %) | 24 of 34 (70.6 %) | |
Duration of BCRF-survival after salvage ePLND (months): 1. mean duration ± SD | 54.5 ± 5.5 | 30.1 ± 25.2 | |
2. median duration | 51.75 | 23.5 | |
3. min-max duration | 49–60 | 4–93 |
